Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.

DESIGN, SETTING, AND PARTICIPANTS The Swedish Obese Subjects (SOS) is a prospective matched cohort study conducted at 25 surgical departments and 480 primary health care centers in Sweden. Of patients recruited between September 1, 1987, and January 31, 2001, 260 of 2037 control patients and 343 of 2010 surgery patients had type 2 diabetes at baseline. For the current analysis, diabetes status was determined at SOS health examinations until May 22, 2013. Information on diabetes complications was obtained from national health registers until December 31, 2012. Participation rates at the 2-, 10-, and 15-year examinations were 81%, 58%, and 41% in the control group and 90%, 76%, and 47% in the surgery group. For diabetes assessment, the median follow-up time was 10 years (interquartile range [IQR], 2-15) and 10 years (IQR, 10-15) in the control and surgery groups, respectively. For diabetes complications, the median follow-up time was 17.6 years (IQR, 14.2-19.8) and 18.1 years (IQR, 15.2-21.1) in the control and surgery groups, respectively.

[1]  Jennette P. Moreno,et al.  Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes , 2014, Current Atherosclerosis Reports.

[2]  A. Ramos-Leví,et al.  Metabolic surgery: quo vadis? , 2014, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[3]  M. Kroh,et al.  Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus , 2013, Annals of surgery.

[4]  N. Maruthur The Growing Prevalence of Type 2 Diabetes: Increased Incidence or Improved Survival? , 2013, Current Diabetes Reports.

[5]  P. Shekelle,et al.  Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. , 2013, JAMA.

[6]  M. Neovius,et al.  Incidence of Rheumatoid Arthritis in Sweden: A Nationwide Population‐Based Assessment of Incidence, Its Determinants, and Treatment Penetration , 2013, Arthritis care & research.

[7]  Deepak L. Bhatt,et al.  Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes , 2013, Diabetes Care.

[8]  E. Disse,et al.  Predictive Factors of Type 2 Diabetes Remission 1 Year After Bariatric Surgery: Impact of Surgical Techniques , 2013, Obesity Surgery.

[9]  G. Bray,et al.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. , 2013, The New England journal of medicine.

[10]  Avis J. Thomas,et al.  Roux-enY Gastric Bypass vs Intensive Medical Management for theControlofType 2 Diabetes , Hypertension , and Hyperlipidemia The Diabetes Surgery Study Randomized Clinical Trial , 2013 .

[11]  P. Schauer,et al.  Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[12]  J. Dixon,et al.  Predicting the Glycemic Response to Gastric Bypass Surgery in Patients With Type 2 Diabetes , 2012, Diabetes Care.

[13]  S. Hunt,et al.  Health benefits of gastric bypass surgery after 6 years. , 2012, JAMA.

[14]  C. Bouchard,et al.  Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. , 2012, The New England journal of medicine.

[15]  Markku Peltonen,et al.  Cardiovascular Events After Bariatric Surgery in Obese Subjects With Type 2 Diabetes , 2012, Diabetes Care.

[16]  Katherine M Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[17]  C. Bouchard,et al.  Bariatric surgery and long-term cardiovascular events. , 2012, JAMA.

[18]  R. Abramof Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes , 2012 .

[19]  R. Ness-Abramof Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes , 2012 .

[20]  S. Haneuse,et al.  A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass , 2012, Obesity Surgery.

[21]  M. Neovius,et al.  Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register , 2010, Annals of the rheumatic diseases.

[22]  Arya M. Sharma,et al.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. , 2010, The New England journal of medicine.

[23]  S. Colagiuri,et al.  Diabesity: therapeutic options , 2010, Diabetes, obesity & metabolism.

[24]  M. Jensen,et al.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.

[25]  Executive Summary: Standards of Medical Care in Diabetes—2009 , 2009, Diabetes Care.

[26]  S. Schinner Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[27]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[28]  Deepak L. Bhatt,et al.  Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. , 2008, JAMA.

[29]  Margaret Anderson,et al.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. , 2008, JAMA.

[30]  G A Naughton,et al.  Exercise for type 2 diabetes mellitus. , 2006, The Cochrane database of systematic reviews.

[31]  Toshiro Tango,et al.  Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. , 2005, Diabetes care.

[32]  C. Schmid,et al.  Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. , 2005, The Cochrane database of systematic reviews.

[33]  C. Schmid,et al.  Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. , 2005, The Cochrane database of systematic reviews.

[34]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[35]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes , 2004 .

[36]  L. Råstam,et al.  Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers , 2000, European Journal of Epidemiology.

[37]  L. Sjöström,et al.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.

[38]  C. DeGeyter Pharmacologic prevention of type 2 diabetes. , 2003, Current women's health reports.

[39]  R. Brolin Results of obesity surgery. , 1987, Gastroenterology clinics of North America.